Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Health Management Associates, Community Health Systems, Elan Corp., and Acura Pharma Under StockCall's Microscope

ACUR, CYH
Health Management Associates, Community Health Systems, Elan Corp., and Acura Pharma Under StockCall's Microscope

LONDON, March 22, 2013 /PRNewswire/ --

The Supreme Court last year upheld President Obama's Affordable Care Act (ACA). The ACA will lead to a major overhaul of the healthcare industry. For-profit hospitals such as Health Management Associates Inc. (NYSE: HMA), and Community Health Systems (NYSE: CYH) are expected to benefit immensely from the ACA in the long-term. Drug delivery companies such as Elan Corporation Plc (NYSE: ELN), and Acura Pharmaceuticals Inc. (NASDAQ: ACUR) are expected to see their costs rise in the near-term due to the healthcare reform. However, the increase in number of insured individuals is expected to benefit the entire healthcare industry in the long-term. On Thursday, the healthcare sector ended mostly lower as the broad market struggled. StockCall has released full comprehensive research on HMA, CYH, ELN, and ACUR and these free technical analyses can be downloaded by signing up at

http://www.stockcall.com/technicalanalysis

Health Management Associates Inc.'s shares fell in trading on Thursday even as the stock touched a 52-week high of $12.50. Health Management Associates Inc. shares ended the day 0.81% lower at $12.28 on volume of 2.07 million. The company's shares have seen a series of highs since the start of this year. Year-to-date, the stock has gained more than 31%, compared to a gain of nearly 8.40% for the S&P 500. Although the for-profit hospital's shares have had excellent run this year, the stock's MACD chart is indicating that the bullish trend may have come to an end. Free technical analysis on HMA available by signing up at

http://www.StockCall.com/HMA032213.pdf

Community Health Systems shares fell sharply in yesterday's trading session. The stock ended the day 1.29% lower at $44.39 on volume of 496,913. The stock saw a pullback after hitting a 52-week high of $45.19. Community Health Systems' shares have outperformed the broad market this year, gaining more than 44%. The stock is currently trading well above its 50-day and 200-day moving averages. The stock's MACD is also trading above the signal line, and the zero-line, which is a bullish signal. Register today and access the free research on CYH at

http://www.StockCall.com/CYH032213.pdf

Shares of Elan Corporation Plc struggled in trading on Thursday. The stock ended the day 0.68% lower at $11.75 on volume of 5.18 million. Elan's shares have traded in a very tight range over the past few trading sessions. The stock has been struggling to break through $12 resistance level. Its MACD has crossed below the signal line yesterday, which is a bearish signal. The company's shares have outperformed the S&P 500 this year, gaining more than 15%. The free report on ELN can be downloaded by signing up now at

http://www.StockCall.com/ELN032213.pdf

Shares of Acura Pharmaceuticals Inc. tumbled in Thursday's trading session. The stock ended the day 6.33% lower at $2.22 on volume of 234,738. Acura's shares pared all of their gains for the year as a result of the sharp decline yesterday. In the last one year, the stock has fallen more than 42%. The company's shares are still trading above their 50-day and 200-day moving averages. However, the stock's MACD chart is indicating that market sentiment has turned bearish on the stock. The stock currently has support at around $2.20. Free report on ACUR can be accessed by registering at

http://www.StockCall.com/ACUR032213.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

http://www.stockcall.com  

SOURCE StockCall.com



USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse